Abstract
Acute undifferentiated leukemia is a rare hematologic malignancy with a poor prognosis. Venetoclax was highly active in two patients with relapsed acute undifferentiated leukemia and should be studied further.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
-
Humans
-
Leukemia, Myeloid, Acute* / drug therapy
-
Sulfonamides / therapeutic use
Substances
-
Bridged Bicyclo Compounds, Heterocyclic
-
Sulfonamides
-
venetoclax